✦ LIBER ✦

Enzymic markers in lymphoproliferative disorders

✍ Scribed by Dr. Martin B. van der Weyden; Peter H. Ellims; T. Eng Gan

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 663 KB
Volume: 14
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830140313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum β2 microglobulin in malignant lymp

Serum β2 microglobulin in malignant lymphoproliferative disorders

✍ Ioannis P. Constantinides; Christina Pathouli; Gerasimos Karvountzis; Perikles P 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Lymphoproliferative disorders in renal t

Lymphoproliferative disorders in renal transplant patients in Japan

✍ Yoshihiko Hoshida; Ting Li; Zhiming Dong; Yasuhiko Tomita; Amane Yamauchi; Jun H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 287 KB 👁 1 views

A new characteristic karyotypic anomaly

A new characteristic karyotypic anomaly in lymphoproliferative disorders

✍ H. Van Den Berghe; C. Parloir; G. David; J. L. Michaux; G. Sokal 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 805 KB

A new characteristic chromosome anomaly t(l1; 14)(q14;q32?) in lymphoproliferative disorders (LPD) is described in 4 cases. The extra material was found on a # 14 chromosome (14q+) and belonged to the long arm of one # 11 chromosome in 3 cases and to the long arm of a #14 in the other case. These ca

Involvement of PI3K in HCV-related lymph

Involvement of PI3K in HCV-related lymphoproliferative disorders

✍ Anna Alisi; Carlo Giannini; Alessandra Spaziani; Patrizio Caini; Anna L. Zignego 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

## Abstract Hepatitis C virus (HCV) core protein has been shown to deregulate cell growth and programmed cell death in hepatoma cells, but only minimal informations are available about its possible role on B‐lymphoproliferative disorders (LPDs). The aim of our work was to analyze the biological act

Phase II study of alemtuzumab in chronic

Phase II study of alemtuzumab in chronic lymphoproliferative disorders

✍ Alessandra Ferrajoli; Susan M. O'Brien; Jorge E. Cortes; Francis J. Giles; Debor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract ## BACKGROUND Pilot studies showed that alemtuzumab is active in lymphoproliferative disorders. The authors conducted a Phase II trial to evaluate the efficacy and safety of alemtuzumab in advanced or refractory chronic lymphoproliferative disorders. ## METHODS Seventy‐eight patients

Lymphoproliferative disorders in Sotos s

Lymphoproliferative disorders in Sotos syndrome: Observation of two cases

✍ Corsello, Giovanni; Giuffrè, Mario; Carcione, Aldo; Cuzto, Margherita L.; Piccio 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Sotos syndrome is included among the overgrowth disorders, most of which have an increased risk of neoplasms. Sotos syndrome does not appear to be related to a specific tumor type, but rather to the development of solid tumors of ectodermal or mesodermal origin in general. We report on two Sotos syn